Tirzepatide is a synthetic peptide analog of the human GIP hormone. It is an innovative “twincretin” that is structurally engineered to bind to and activate both the GIP and GLP-1 receptors. These incretin hormones are involved in regulating blood sugar.

By activating these receptors, Tirzepatide enhances both first- and second-phase insulin secretion and reduces glucagon levels, all in a glucose-dependent manner. Its action also leads to slowed gastric emptying and a reduction in appetite, which contributes to its effects on glycemic control and weight reduction.

This product is a 20mg vial intended for research and laboratory purposes only. It is not for human or veterinary use.

• CAS Number: 2023788-19-2